{"id":"W4379282852","doi":"10.1200/jco.2023.41.16_suppl.tps3153","title":"TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Prostate cancer; Internal medicine; Oncology; Cancer; Combination therapy; Bevacizumab; Cancer research; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001788656,0.002181795,0.001364561,0.0006406564,0.0004332743,0.001222736,0.001219174,0.001593445,0.00498655],"category_scores_gemma":[0.0008787421,0.0007785974,0.0013429,0.0006343062,0.0009402749,0.001093104,0.0004958587,0.002873192,0.00150937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001474748,"about_ca_system_score_gemma":0.001919134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001887999,"about_ca_topic_score_gemma":0.004570238,"domain_scores_codex":[0.9995189,0.0002335147,0.00001757196,0.00007803198,0.00004785441,0.0001041975],"domain_scores_gemma":[0.9993382,0.00007179081,0.0001466033,0.00005455404,0.00004367542,0.0003450826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6863989,0.1129207,0.0137082,0.0009368524,0.00170018,0.0005156496,0.000626141,0.004167112,0.06840637,0.0005597857,0.01117945,0.09888077],"study_design_scores_gemma":[0.5409942,0.4330057,0.01439417,0.00004112167,0.0004821014,0.0006726654,0.0001104609,0.001439272,0.004368498,0.0002738045,0.004175668,0.00004228801],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889314,0.001620794,0.0005845306,0.0005541532,0.00008501704,0.002917005,0.003144175,0.0001911182,0.001971651],"genre_scores_gemma":[0.9785998,0.001888436,0.002352072,0.001204327,0.0001761839,0.00424908,0.0074111,0.00009222106,0.004026819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00498655,"threshold_uncertainty_score":0.01668167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.139887455660775,"score_gpt":0.5423854401283179,"score_spread":0.4024979844675429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}